Earnings
AMPH
17.46
+1.87%
0.32
Currencies: USD
Items
Cash and Cash Equivalents
Short-term Investments
Short-term Securities
Accounts Receivable
Notes Receivable
Interest Receivable
Other Receivables
Prepayments
Inventories
Holding Assets for Sale
Unamortized Expenditures
Other Current Assets
Total Current Assets
Fixed Assets Net
Long-term Receivables
Long-term Investments
Deferred Tax Asset
Goodwill
Intangible Assets
Long-term Deferred Expenses
Other Non-current Assets
Total Non-current Assets
Total Assets
Short/Current Long Term Debt
Accounts Payable
Notes Payable
Taxes and Dues Payable
Salary Payable
Financing Expenses Payable
Other Payable
Advance Receipt
Accrued Expenses
Deferred Income
Holding Liabilities For Sale
Financial Derivative Liabilities
Other Current Liabilities
Total Current Liabilities
Long-term Debt
Long-term Payables
Long-term Deferred Income
Long-term Deferred Tax Liabilities
Other Non-current Liabilities
Total Non-current Liabilities
Total Liabilities
Common Stocks
Additional Paid-in Capital
Retained Earnings
Treasury Shares
Other Equity Instruments
Minority Interest
Equities Attributable to Parent Company
Total Equities
Total Liabilities and Equities
FY 2020-12-31
92.64M
12.98M
--
66.00M
--
--
385.00K
--
96.83M
--
6.78M
4.07M
279.68M
280.71M
--
--
--
3.94M
36.67M
--
30.23M
351.55M
631.24M
--
24.36M
0.00
--
--
--
--
--
74.50M
--
--
--
1.08M
112.20M
34.19M
--
--
741.00K
35.38M
116.73M
182.51M
5000.00
410.06M
117.77M
-121.81M
--
46.42M
402.31M
448.72M
631.24M
FY 2019-12-31
73.69M
11.68M
--
45.38M
--
--
311.00K
--
110.50M
--
9.54M
4.16M
255.24M
253.55M
--
--
--
3.63M
37.52M
--
37.03M
331.73M
586.97M
--
25.06M
0.00
--
--
--
77.05M
--
55.16M
--
--
--
2.04M
90.01M
39.39M
--
--
867.00K
29.17M
115.60M
159.44M
5000.00
367.31M
116.37M
-97.63M
--
46.16M
381.37M
427.53M
586.97M
FY 2018-12-31
86.34M
2.83M
--
52.16M
--
--
49.00K
--
69.32M
--
5.49M
4.16M
220.34M
210.42M
--
--
--
3.95M
38.32M
--
40.54M
293.22M
513.56M
--
31.32M
0.00
--
--
--
--
--
56.09M
--
--
--
1.19M
106.83M
31.98M
--
--
1.03M
9.36M
74.29M
149.20M
5000.00
344.43M
67.48M
-75.48M
--
31.92M
332.44M
364.36M
513.56M
FY 2017-12-31
65.59M
2.63M
--
36.00M
--
--
6.04M
--
63.61M
--
9.75M
4.16M
187.78M
180.54M
--
--
--
4.46M
40.68M
--
37.61M
263.29M
451.07M
--
16.63M
0.00
--
--
--
--
--
40.93M
--
--
--
3.33M
67.19M
40.84M
--
--
1.36M
7.94M
50.14M
117.34M
5000.00
313.89M
72.64M
-50.70M
--
0.00
333.74M
333.74M
451.07M
FY 2016-12-31
72.35M
527.00K
--
26.78M
--
--
22.00K
--
79.75M
--
3.27M
1.39M
184.10M
152.94M
--
--
--
3.98M
46.33M
--
40.39M
243.64M
427.74M
--
16.20M
0.00
--
--
--
--
--
31.35M
--
--
--
7.71M
60.62M
32.36M
--
--
1.46M
4.05M
37.87M
98.48M
5000.00
283.12M
70.86M
-20.03M
--
--
329.25M
329.25M
427.74M

FY: Financial Year. It represents annual report.

Q: Quarter Report. Q1、Q2、Q3、Q4 represent three-month periodic financial reports.

Check out AMPH latest quarterly and annual financial reports. There are also historical financial reports for you to reference. You can analyze Amphastar Pharms recent business situations by check its income statements, balance sheets, cash flow statements and other tables. This information may help you make smarter investment decisions.